Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Azilsartan. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 known ✓ | P30556 | 1/20 | 0.57 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.70 |
| ▸ | PPARG | P37231 | 2/20 | 0.57 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.57 |
| ▸ | EGFR | P00533 | 1/20 | 0.57 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.57 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.57 |
| ▸ | HTR2C | P28335 | 1/20 | 0.57 |
| ▸ | HTR2B | P41595 | 1/20 | 0.57 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.57 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Azilsartan SCHEMBL969380 | 0.98 | AGTR2 (0.70) | AGTR2PPARGABCB11EGFRERBB2 | |
| Azilsartan SCHEMBL29409444 | 0.93 | AGTR2 (0.65) | AGTR2PPARGABCB11EGFRERBB2 | |
| Azilsartan SCHEMBL167538 | 0.92 | AGTR2 (0.72) | AGTR2PPARGABCB11EGFRERBB2 | |
| Azilsartan SCHEMBL29687472 | 0.92 | AGTR2 (0.72) | AGTR2PPARGABCB11EGFRERBB2 | |
| Azilsartan SCHEMBL15552225 | 0.91 | AGTR2 (0.71) | AGTR2PPARGABCB11EGFRERBB2 | |
| Azilsartan SCHEMBL969381 | 0.91 | AGTR2 (0.71) | AGTR2PPARGABCB11EGFRERBB2 | |
| SCHEMBL965217 | 0.90 | AGTR2 (0.75) | AGTR2PPARGABCB11EGFRERBB2 | |
| SCHEMBL30206762 | 0.90 | AGTR2 (0.82) | AGTR2PPARGABCB11EGFRERBB2 | |
| SCHEMBL30539216 | 0.90 | AGTR2 (0.82) | AGTR2PPARGABCB11EGFRERBB2 | |
| SCHEMBL28653349 | 0.90 | AGTR2 (0.82) | AGTR2PPARGABCB11EGFRERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010075347-A2 | METHODS OF TREATING HYPERTENSION WITH AT LEAST ONE ANGIOTENSIN II RECEPTOR BLOCKER AND CHLORTHALIDONE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-07-01 | — | — | WO | claimed |